Bruce C. Cozadd is the CEO and Chairman of Jazz Pharmaceuticals, Inc., which he co-founded in 2003. He stepped into the CEO role in April 2009 and has been steering the company ever since. Cozadd's leadership is marked by his...

Bruce C. Cozadd is the CEO and Chairman of Jazz Pharmaceuticals, Inc., which he co-founded in 2003. He stepped into the CEO role in April 2009 and has been steering the company ever since. Cozadd's leadership is marked by his deep involvement in the pharmaceutical industry, particularly in developing and promoting impactful treatments. One interesting fact is that his compensation package saw a significant jump in 2011, largely driven by a performance bonus and the vesting of stock options linked to a merger with Azur Pharma. Throughout his career, he has managed impressive stock valuation fluctuations, peaking around $57 million in 2021. His tenure has not only focused on growth but has also led to noteworthy corporate acquisitions, broadening Jazz Pharmaceuticals' portfolio. Cozadd's strategic decisions directly contribute to the company's market presence and future direction. Currently, at age 60, he continues to spearhead innovation and operational excellence at Jazz Pharmaceuticals, a role he has embraced for over a decade.